Publications
Publications
Show Results For
- All HBS Web
(1,953)
- Faculty Publications (716)
Property
→
- November 1994 (Revised November 1994)
- Case
MW Petroleum Corporation (A)
By: Timothy A. Luehrman, Peter Tufano and Barbara Wall
Amoco Corp. is negotiating to sell a wholly-owned subsidiary, MW Petroleum, to Apache Corp. MW owns large reserves of oil and gas comprising many properties at different stages of engineering, development, and production. The proposed acquisition is a large one for... View Details
- November 1994 (Revised January 2006)
- Background Note
An Introduction to Patents and Trade Secrets
By: Josh Lerner
Provides an overview of patent and trade secret protection. Also discusses the legal processes through which intellectual property is protected and litigated. View Details
- summer 1994
- Article
The Importance of Patent Scope: An Empirical Analysis
By: J. Lerner
Keywords: Patents
- March 1994
- Article
Expropriation and Inventions: Appropriable Rents in the Absence of Property Rights
By: J. Anton and Dennis Yao
We analyze the problem faced by a financially weak independent inventor when selling a valuable, but easily imitated, invention for which no property rights exist. The inventor can protect his or her intellectual property by negotiating a contingent contract (with a... View Details
- January 1994 (Revised November 1997)
- Case
Aberlyn Capital Management: July 1993
By: Josh Lerner and Peter Tufano
Aberlyn Capital Management, a venture leasing firm specializing in providing capital to biotechnology firms, proposes to introduce a new product. Aberlyn will base a lease on an intangible product: the patent of a biotechnology firm. This poses a series of short and... View Details
- December 1993 (Revised January 1994)
- Case
Montana Land Reliance
By: Forest L. Reinhardt and Thomas Patterson
The Montana Land Reliance is a small not-for-profit organization in the business of creating conservation easements on private lands in Montana. The easements preserve the scenic character and recreational value of the lands by precluding subdivision and other forms of... View Details
- December 1993 (Revised April 2006)
- Case
Marriott Corporation (A)
By: Lynn S. Paine and Charles A. Nichols
Marriott Corp.'s chairman and CEO must decide whether to recommend a restructuring of the company to the board of directors. The proposal he is considering would split the Marriott Corp., a premier hotel developer, owner, and manager, into two separate companies by a... View Details
- September 1993
- Supplement
Manufacturing at ALZA: The Right Prescription? (B)
ALZA, a drug delivery company, must decide what and for whom to manufacture. In the past, it has licensed to pharmaceutical companies its patented system for the slow release of drugs into the human system. Therefore the company has little experience in choice of drug... View Details
- August 1993
- Case
USAA: Business Process Review for the Great Lakes Region
By: James L. Heskett and Roger H. Hallowell
USAA proposes to develop a new set of processes for its property and casualty division. The case focuses on processes used in automobile claims. View Details
- Article
Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations
By: Rebecca M. Henderson, Adam Jaffe and Manuel Trajtenberg
- April 1993 (Revised February 1996)
- Supplement
ALZA and Bio-Electro Systems (B1): Rights Offering Strategy
By: Josh Lerner and Peter Tufano
Supplements the (A) case. Describes the CEO's decision. View Details
- April 1993 (Revised February 1996)
- Supplement
ALZA and Bio-Electro Systems (B2): The Rights Offering
By: Josh Lerner and Peter Tufano
Supplements the (A) case. Describes the implementation of the CEO's decision. View Details
Keywords: Intellectual Property
- March 1993 (Revised July 1994)
- Case
Gerber Products Company: Investing in the New Poland
By: Debora L. Spar
Examines Gerber Products Co.'s evaluation of Alima S.A., one of Poland's largest food processing plants, as a potential overseas investment in 1991. Factors that influenced Gerber's decision are discussed in detail: property rights, taxation issues, and Poland's... View Details
- October 1992 (Revised September 1993)
- Case
Nopane Advertising Strategy
By: David E. Bell
Nopane is a proprietary drug that sells in much of the United States. It faces substantial competition. The brand manager is undertaking an experiment to determine whether ad copy should be emotional-based or rational-based. The data and associated regression results... View Details
- May 1992 (Revised April 1995)
- Teaching Note
Colliers International Property Consultants, Teaching Note
By: Nitin Nohria
Teaching Note for (9-490-049). View Details
Keywords: Real Estate Industry
- May 1992 (Revised August 1993)
- Case
Forest Policy in Malaysia
The governments of Malaysia and the Malaysian State of Sarawak need to assess possible changes in forest policy. Environmentalist pressure threatens traditional market relationships and patterns of business-government interaction. Harvest regulations, subsidies, trade... View Details
- February 1992 (Revised April 1995)
- Case
Pfizer: Global Protection of Intellectual Property
By: Lynn S. Paine and Michael Santoro
Top officials at Pfizer are assessing their strategy for improving protection of Pfizer's patents around the world. The outcome of the Uruguay Round of the GATT negotiations is uncertain, and it is not clear whether an acceptable intellectual property protection... View Details
- January 1992 (Revised August 1992)
- Case
Lexon Corp. (A)
By: Lynn S. Paine
A general manager at Lexon Computer Corp. must decide whether interception and surveillance of employees' e-mail is acceptable company practice, and whether to follow the advice of his computer operations manager who wants to fire the person who complained that the... View Details
- 1991
- Working Paper
Manufacturing, Firm Boundaries, and the Protection of Intellectual Property
By: Gary P. Pisano and Paul Mang
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details